For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. Chloroquine parenteral Is hydroxychloroquine sulfate a sulfa drug Drusen plaquenil Summary Dermatomyositis is found among people who take Plaquenil, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months, also take medication Rituxan, and have Pain. This study is created by eHealthMe based on reports of 48,911 people who have side effects when taking Plaquenil from Food. Amyopathic Dermatomyositis ADM and Hypomyopathic Dermatomyositis HDM, together referred to as Clinically Amyopathic Dermatomyositis CADM, are subsets of Dermatomyositis DM, one of the Idiopathic Inflammatory Myopathies. The cause is unclear and there is no cure. Drugs Used to Treat Dermatomyositis The following list of medications are in some way related to, or used in the treatment of this condition. All drug classes - alkylating agents 1 - antimetabolites 2 - antirheumatics 5 - antimalarial quinolines 2 - antipsoriatics 2 - glucocorticoids 3 - selective immunosuppressants 3 - other immunosuppressants 3 A health care provider may consider these conditions in the table below when making a diagnosis. This information comes from a database called the Human Phenotype Ontology (HPO) Related diseases are conditions that have similar signs and symptoms. Plaquenil for amyopathic dermatomyositis UpToDate, Clinically Amyopathic Dermatomyositis CADM Myositis. Chloroquine injection side effectsIs plaquenil safe for breastfeeding For most people, there’s no cure for dermatomyositis. Treatment can improve the condition of your skin and muscle weakness. Available treatments include medication, physical therapy, and surgery. Dermatomyositis Causes, Symptoms, and Treatment. List of Dermatomyositis Medications 12 Compared -. How effective is Plaquenil for Dermatomyositis by.. The skin component of dermatomyositis is assessed by means physical examination in conjunction with history taking. The Cutaneous Dermatomyositis Disease Area and Severity Index CDASI, the Dermatomyositis Skin Severity Index DSSI, and the Cutaneous Assessment Tool CAT skin indices have been developed as outcome instruments. Jun 18, 2019 Clinically amyopathic DM evolving into classic DM is typical in patients with cutaneous DM with disease onset in the muscle 6 months prior to clinical presentation. Juvenile dermatomyositis is a subset of DM occurring in patient 18 years old or less. 8. Polymyositis is a disease state that shares similar pathophysiology with DM. In clinically amyopathic dermatomyositis, the subtypes to be familiar with are based on two autoantibody profiles, with a cluster of clinical phenotypes linked with these autoantibodies.